Synthesis and Biological Evaluation ofdl-4,4-Difluoroglutamic Acid anddl-γ,γ-Difluoromethotrexate

Publisher Website
Google Scholar
Abstract
Dl-4,4-Difluoroglutamic acid (dl-4,4-F2Glu) and its methotrexate analogue, dl-γ,γ-difluoromethotrexate (dl-γ,γ-F2MTX), were synthesized and evaluated as alternate substrates or inhibitors of folate-dependent enzymes. Synthesis of dl-4,4-F2Glu involved the nitroaldol reaction of ethyl nitroacetate with a difluorinated aldehyde ethyl hemiacetal as a key step. Attempted ligation of dl-4,4-F2Glu to methotrexate (MTX), catalyzed by human folylpoly-γ-glutamate synthetase (FPGS), revealed that dl-4,4-F2Glu is a poor alternate substrate. dl-γ,γ-F2MTX was synthesized by a route proceeding through N-[4-(methylamino)benzoyl]-4,4-difluoroglutamic acid di-tert-butyl ester followed by alkylation with 6-(bromomethyl)-2,4-pteridinediamine hydrobromide. dl-γ,γ-F2MTX was found to be neither a substrate nor an inhibitor of human FPGS. The fluorinated analogue of MTX, however, inhibits DHFR and cell growth with the same potency as MTX.

This publication has 12 references indexed in Scilit: